SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): May 13, 2008 (May 8,
2008)
CHEMBIO
DIAGNOSTICS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
0-30379
|
|
88-0425691
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
Incorporation)
|
|
|
|
Identification
Number)
|
|
|
3661
Horseblock Road
|
|
|
|
|
Medford,
NY 11763
|
|
|
|
|
(Address
of principal executive offices)
|
|
|
|
|
631-924-1135
|
|
|
|
|
(Registrant’s
Telephone Number)
|
|
|
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
7.01. REGULATION FD DISCLOSURE.
On May 8,
2008, Chembio Diagnostics, Inc. (the “Company”) issued a press release entitled
“Chembio to Host Conference Call to Discuss First Quarter 2008 Financial
Results.” A copy of the press release is furnished herewith as
Exhibit 99.1.
On
May 13, 2008, the Company also issued a press release entitled “Chembio Reports
First Quarter 2008 Results.” A copy of the press release is furnished herewith
as Exhibit 99.2.
All of
the information in this Item 7.01 of this Form 8-K is being furnished and
shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, or otherwise subject to the liabilities of that
section. The information in this Item 7.01 of this Form 8-K also shall not
be deemed to be incorporated by reference into any filing under the Securities
Act of 1933, as amended, or the Securities Exchange Act of 1934, except to the
extent that the Company specifically incorporates it by reference.
ITEM
9.01. FINANCIAL STATEMENTS AND EXHIBITS
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date: May 13,
2008 CHEMBIO
DIAGNOSTICS, INC.
By: /s/ Lawrence A.
Siebert
Lawrence
A. Siebert
Chief
Executive Officer